A Class III device is a category of medical device that carries the highest risk classification by regulatory bodies such as the FDA. These devices are typically used to support or sustain human life, are of substantial importance in preventing impairment of human health, or present a potential unreasonable risk of illness or injury.
Class III devices undergo the most stringent regulatory controls and require premarket approval (PMA) before they can be marketed. Examples of Class III devices include implantable pacemakers, breast implants, and automated external defibrillators (AEDs). The extensive review process for these devices aims to ensure their safety and effectiveness for intended use.
The term ‘Class III Device’ is crucial in clinical research as it signifies the highest level of regulatory scrutiny and risk associated with a medical device. Understanding this classification is essential for researchers, as it informs the study design, safety protocols, and regulatory requirements that must be met during clinical trials involving these devices.
Clinical researchers must be aware of the extensive documentation, rigorous testing, and comprehensive data collection required for Class III devices. This knowledge ensures that studies are conducted with the appropriate level of caution and thoroughness, ultimately contributing to the development of safe and effective medical technologies that can significantly impact patient care.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant